ImmuneID is a precision immunology company. Founded in 2020, ImmuneID is backed by investors that include ARCH Venture Partners, Pitango Venture Capital, In-Q-Tel, Longwood Fund, and Xfund and is headquartered in Boston.
FOUNDED:
2020
INDUSTRY:
Biotechnology, Therapeutics
You are seconds away from signing up for the hottest list in New York Tech!
Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.
